It's Down, It's Up

As world markets fluctuate, FierceBiotech writes that the biotech sector is a bit shaken. On Monday, the US stock market fell dramatically in the morning before rising again in the afternoon, with the New York Times noting that the decline likely stemmed from concerns regarding the slowing of the Chinese economy.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.